Proskauer’s multidisciplinary Life Sciences Group combines deep industry knowledge with technical and regulatory experience, transactional strength, and seasoned dispute resolution capabilities. We bring together decades of experience across transaction structures, disputes, therapeutic areas, and stages of the life sciences business and product life cycle, advising product sponsors, investors, and collaboration partners. We advise businesses on developing patent portfolios to maximize exclusivity, navigating competitive IP landscapes, assessing and mitigating freedom-to-operate risks, structuring clinical trials, filling pipelines and spinning off technologies, executing commercial, strategic, and financing transactions, raising capital, and navigating the health care and FDA regulatory landscape. We also help clients resolve bet-the-company antitrust, intellectual property, and commercial disputes and guide them through significant federal regulatory interactions. Our integrated approach provides coordinated, seamless service to clients around the globe.

Our Life Sciences Group delivers strategic, practical advice across disciplines, borders, and stages of growth. We represent public and private pharmaceutical, biotechnology, and medical technology companies; private equity sponsors; private credit lenders; private investment funds; asset managers and other investors; medical centers; CROs; CDMOs and CMOs; and other strategic partners that power the industry. Whether a client is forming a company, raising or deploying capital, designing IP strategy, structuring an acquisition, license, or research collaboration, preparing for clinical trials or commercialization, scaling manufacturing, or protecting a core asset in litigation, Proskauer provides industry-calibrated counsel aligned with business goals.